Literature DB >> 16476198

Eosinophil Function in Eosinophil-associated Gastrointestinal Disorders.

Simon P Hogan1, Marc E Rothenberg.   

Abstract

Eosinophil-associated gastrointestinal disorders (EGIDs) are characterized by a rich eosinophilic inflammation of the gastrointestinal tract in the absence of known causes for eosinophilia or other gastrointestinal disorders. These disorders include eosinophilic esophagitis, eosinophilic gastritis, eosinophilic gastroenteritis, eosinophilic enteritis, and eosinophilic colitis, and are being recognized with increasing frequency. Clinical studies suggest that eosinophils have a pathogenic role in EGID; however, the function of eosinophils in these disorders remains an enigma. In this review, we briefly describe the clinical features of EGID of the esophagus, small bowel, and colon. We summarize recent experimental analysis examining the underlying contribution of eosinophils to disease pathogenesis and discuss possible therapeutic approaches for the treatment of these diverse diseases.

Entities:  

Mesh:

Year:  2006        PMID: 16476198     DOI: 10.1007/s11882-006-0013-8

Source DB:  PubMed          Journal:  Curr Allergy Asthma Rep        ISSN: 1529-7322            Impact factor:   4.919


  51 in total

Review 1.  Gastrointestinal eosinophils in health and disease.

Authors:  M E Rothenberg; A Mishra; E B Brandt; S P Hogan
Journal:  Adv Immunol       Date:  2001       Impact factor: 3.543

2.  Serum IgE in eosinophilic gastroenteritis. Response to intestinal challenge in two cases.

Authors:  J H Caldwell; J I Tennenbaum; H A Bronstein
Journal:  N Engl J Med       Date:  1975-06-26       Impact factor: 91.245

3.  Eosinophilic esophagitis.

Authors:  Richard J Noel; Philip E Putnam; Marc E Rothenberg
Journal:  N Engl J Med       Date:  2004-08-26       Impact factor: 91.245

Review 4.  The effects of glucocorticoids on human eosinophils.

Authors:  R P Schleimer; B S Bochner
Journal:  J Allergy Clin Immunol       Date:  1994-12       Impact factor: 10.793

5.  Differential regulation of epithelial-derived C-C chemokine expression by IL-4 and the glucocorticoid budesonide.

Authors:  C Stellato; S Matsukura; A Fal; J White; L A Beck; D Proud; R P Schleimer
Journal:  J Immunol       Date:  1999-11-15       Impact factor: 5.422

Review 6.  Chemokines in asthma: cooperative interaction between chemokines and IL-13.

Authors:  Nives Zimmermann; Gurjit Khurana Hershey; Paul S Foster; Marc E Rothenberg
Journal:  J Allergy Clin Immunol       Date:  2003-02       Impact factor: 10.793

Review 7.  The pathobiology of eosinophilic gastroenteritis of childhood: is it really the eosinophil, allergic mediated, or something else?

Authors:  Peter Ngo; Glenn Furuta; Wesley Burks
Journal:  Curr Gastroenterol Rep       Date:  2004-12

8.  Intratracheal IL-13 induces eosinophilic esophagitis by an IL-5, eotaxin-1, and STAT6-dependent mechanism.

Authors:  Anil Mishra; Marc E Rothenberg
Journal:  Gastroenterology       Date:  2003-11       Impact factor: 22.682

9.  Milk- and soy protein-induced enterocolitis: evidence for lymphocyte sensitization to specific food proteins.

Authors:  G J Van Sickle; G K Powell; P J McDonald; R M Goldblum
Journal:  Gastroenterology       Date:  1985-06       Impact factor: 22.682

Review 10.  Chemokines in eosinophil-associated gastrointestinal disorders.

Authors:  Simon P Hogan; Marc E Rothenberg; Elizabeth Forbes; Vanessa E Smart; Klaus I Matthaei; Paul S Foster
Journal:  Curr Allergy Asthma Rep       Date:  2004-01       Impact factor: 4.919

View more
  16 in total

Review 1.  Therapeutic strategies for harnessing human eosinophils in allergic inflammation, hypereosinophilic disorders, and cancer.

Authors:  Zhaleh J Amini-Vaughan; Margarita Martinez-Moczygemba; David P Huston
Journal:  Curr Allergy Asthma Rep       Date:  2012-10       Impact factor: 4.806

Review 2.  Eosinophils in the gastrointestinal tract.

Authors:  Esi S N Lamousé-Smith; Glenn T Furuta
Journal:  Curr Gastroenterol Rep       Date:  2006-10

Review 3.  An Overlook to the Characteristics and Roles Played by Eotaxin Network in the Pathophysiology of Food Allergies: Allergic Asthma and Atopic Dermatitis.

Authors:  Zahra Ahmadi; Gholamhossein Hassanshahi; Hossein Khorramdelazad; Nahid Zainodini; Leila Koochakzadeh
Journal:  Inflammation       Date:  2016-06       Impact factor: 4.092

Review 4.  Eosinophilic esophagitis: New insights in pathogenesis and therapy.

Authors:  Michele Pier Luca Guarino; Michele Cicala; Jose Behar
Journal:  World J Gastrointest Pharmacol Ther       Date:  2016-02-06

Review 5.  Genetics of eosinophilic esophagitis.

Authors:  L C Kottyan; M E Rothenberg
Journal:  Mucosal Immunol       Date:  2017-02-22       Impact factor: 7.313

6.  Eosinophilic gastrointestinal diseases--clinically diverse and histopathologically confounding.

Authors:  Seema Aceves; Ikuo Hirano; Glenn T Furuta; Margaret H Collins
Journal:  Semin Immunopathol       Date:  2012-07-29       Impact factor: 9.623

Review 7.  Eosinophilic esophagitis: the newest esophageal inflammatory disease.

Authors:  Dan Atkins; Robert Kramer; Kelley Capocelli; Mark Lovell; Glenn T Furuta
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2009-05       Impact factor: 46.802

8.  Multisystemic eosinophilia resembling hypereosinophilic syndrome in a colony-bred owl monkey (Aotus vociferans).

Authors:  Alfonso S Gozalo; Helene F Rosenberg; William R Elkins; Enrique J Montoya; Richard E Weller
Journal:  J Am Assoc Lab Anim Sci       Date:  2009-05       Impact factor: 1.232

9.  Cooperative role of macrophages and neutrophils in host Antiprotozoan resistance in mice acutely infected with Cryptosporidium parvum.

Authors:  Dan Takeuchi; Vickie C Jones; Makiko Kobayashi; Fujio Suzuki
Journal:  Infect Immun       Date:  2008-06-02       Impact factor: 3.441

10.  Characteristics of allergic colitis in breast-fed infants in the absence of cow's milk allergy.

Authors:  Kriszta Molnár; Petra Pintér; Hajnalka Győrffy; Aron Cseh; Katalin Eszter Müller; András Arató; Gábor Veres
Journal:  World J Gastroenterol       Date:  2013-06-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.